Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 6
2021 5
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases.
Kamagata K, Andica C, Kato A, Saito Y, Uchida W, Hatano T, Lukies M, Ogawa T, Takeshige-Amano H, Akashi T, Hagiwara A, Fujita S, Aoki S. Kamagata K, et al. Among authors: takeshige amano h. Int J Mol Sci. 2021 May 14;22(10):5216. doi: 10.3390/ijms22105216. Int J Mol Sci. 2021. PMID: 34069159 Free PMC article. Review.
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in Japan.
Oyama G, Burq M, Hatano T, Marks WJ Jr, Kapur R, Fernandez J, Fujikawa K, Furusawa Y, Nakatome K, Rainaldi E, Chen C, Ho KC, Ogawa T, Kamo H, Oji Y, Takeshige-Amano H, Taniguchi D, Nakamura R, Sasaki F, Ueno S, Shiina K, Hattori A, Nishikawa N, Ishiguro M, Saiki S, Hayashi A, Motohashi M, Hattori N. Oyama G, et al. Among authors: takeshige amano h. Sci Rep. 2023 Mar 14;13(1):3600. doi: 10.1038/s41598-023-29382-6. Sci Rep. 2023. PMID: 36918552 Free PMC article.
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study.
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Nakamura R, Tsunemi T, Ogawa T, Eguchi H, Daida K, Kurita N, Ueno SI, Fukae J, Sako W, Shiina K, Nakajima S, Oji Y, Wakamori R, Saiki S, Nishioka K, Okuzumi A, Taniguchi D, Takeshige-Amano H, Fuse A, Nakajima A, Kano M, Kamo H, Yamashita Y, Shindo A, Yanagisawa N, Hattori N. Hatano T, et al. Among authors: takeshige amano h. Mov Disord Clin Pract. 2024 Apr;11(4):352-362. doi: 10.1002/mdc3.13972. Epub 2024 Jan 24. Mov Disord Clin Pract. 2024. PMID: 38264844 Free PMC article. Clinical Trial.
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Takeshige-Amano H, et al. Mov Disord. 2020 Aug;35(8):1438-1447. doi: 10.1002/mds.28068. Epub 2020 May 1. Mov Disord. 2020. PMID: 32357260 Free PMC article.
Neurocognitive and psychiatric disorders-related axonal degeneration in Parkinson's disease.
Andica C, Kamagata K, Hatano T, Saito Y, Uchida W, Ogawa T, Takeshige-Amano H, Hagiwara A, Murata S, Oyama G, Shimo Y, Umemura A, Akashi T, Wada A, Kumamaru KK, Hori M, Hattori N, Aoki S. Andica C, et al. Among authors: takeshige amano h. J Neurosci Res. 2020 May;98(5):936-949. doi: 10.1002/jnr.24584. Epub 2020 Feb 5. J Neurosci Res. 2020. PMID: 32026517 Free PMC article.
White matter alterations in Parkinson's disease with levodopa-induced dyskinesia.
Ogawa T, Hatano T, Kamagata K, Andica C, Takeshige-Amano H, Uchida W, Saito Y, Shimo Y, Oyama G, Umemura A, Iwamuro H, Ito M, Hori M, Aoki S, Hattori N. Ogawa T, et al. Among authors: takeshige amano h. Parkinsonism Relat Disord. 2021 Sep;90:8-14. doi: 10.1016/j.parkreldis.2021.07.021. Epub 2021 Jul 24. Parkinsonism Relat Disord. 2021. PMID: 34325387 Free article.
21 results